Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yup, and if you think the actions in the Ukraine are stalling any acquisition announcements, I wonder what will happen when China goes into Taiwan...
It looks ike it might be a long wait.
Found this on Yahoo.
Economy might have some acquisition targets setup in discount territory. But not sure if the target is a privately held company.
https://finance.yahoo.com/news/will-the-russia-ukraine-war-fed-rate-hikes-the-ipo-market-132303765.html
After a record-setting 2021, the IPO market has had a much more challenging start to this year — and the Russia-Ukraine war has only further complicated compan...
Exactly 1 week later, 5 shares of NVAC traded hands today for a total of $49.02
I still feel everyone has their shares and are holding, waiting for the announcement of the acquisition target.
Keeping in mind that there are big players, such as Yakira Capital Management with $10 million (1 million shares) and Skyview Investment Advisers, LLC. with $2 million (200,000 shares), I still feel pretty confident that NorthView is going to have to perform or risk disappointing...and soon.
I further believe that the activities in the Ukraine are stalling the announcement of the acquisition, as no one wants to see such an important Press Release being over shadowed by 24/7 coverage of the war going on over there.
Hopefully the 2 nations can come to some kind of a peace agreement in the very near future, and that we can get a resolution there with a long enough break for the announcement before China begins the next crisis in Taiwan.
It is sad that so many have been waiting for this opportunity (weak and feeble leadership at the top ranks of the United States), and that Biden and Kamala (et al) have given them just what they were looking for.
Fortunately, Trump is standing by, ready to restore this country to its original greatness, but don't expect too much salvation until the Great Red Sweep (aka, The Red Tsunami) on November 8th.
It is going to be a long, drawn out summer.
Yes, just running sideways, waiting for the acquisition target announcement.
Today:
NVAC = 17,556 shares @ $9.80 = $175,000 (average volume is 12.6 times larger)
NVACW = 10,300 @ .1588 = $1,636.00
NVACR = 2,437 @ .1494 = $365.00
I still think we will need the Russian invasion of Ukraine to quiet down before a target company is announced.
I now hope to hear by April 22nd.
Godspeed.
I don't think I have seen a single share of NVACR trade in the last 2 days, not since the 2 shares that traded on Wednesday.
Shares of NVAC appear to have been ALL buys today (99,756).
So too can be said of NVACW (ALL buys), 247,871
Looks like things are leveling off off and going to travel sideways for a while until things get stirred up by the announcement of an acquisition target.
Yakira Capital Management = $10 million.
Skyview Investment Advisers, LLC. $2 million.
...as of 12/31/2021
Yesterday's volume of NVAC was 797,589 shares traded, and finished off at 1 penny below the 52-week high of $9.84
Roughly speaking, almost $8 million worth of stock traded hands.
And yet, lol, only 2 shares of NVACR sold for just over 26 cents...to me!
I don't know if that is good or bad, but for the first time in my life, I actually bought 100% of the shares traded for a company in a single day.
I do still stick with my belief that now the big boys are focused on consolidating and trading the stock, rather than "pussy footing around" with the "penny-stock" options...
...and that the options are where the biggest ROIs will be found...
Not even 10 am on March 2 and already we see over 221k shares of NVAC trading hands.
@ $9.82, that is over $2 million dollars.
Not at the 52 week closing high of $9.83 (just a penny shy), but certainly well above the 52 week low of $9.69 (by a healthy 13 cents; not bad for a SPAC pre-announcement).
NVACR sold 2 shares for a total of 26 cents (which were purchased by me!).
NVACW sold 5,000 shares.
Still holding strong to my belief that the big players are buying up NVAC with the dollars they received by cleaning up and selling off their Rights and Warrants (which they had in their portfolios when NVACU split up into its 3 components back on January 21, 2022.
They, the big players, the capital management companies such as (but not limited to) Yakira Investment Advisers {post #40} and SkyView Investment Advisers {post #42} seem to be CONSOLIDATING to play where the big boys play.
They seem to not want to be bothered with the "penny stock" options portion of this stock, which literally is 70 shares of NVACR or NVACW to 1 share of NVAC.
I am sticking to the belief that the options will have a much greater % swing NORTH, when the acquisition target is announced, than the stock itself.
I'm hoping for a 3x to 5x better return (ie: if NVAC goes from $10 to $20 upon acquisition announcement, a 100% ROI, I myself am hoping NVACR would go from .20 to somewhere between .60 to $1).
I think once a target is announced, the "risk" associated with NVACR is reduced dramatically.
In theory, if one were to hold until the merger is completed, then 10 NVACR would be converted to a share of NVAC, and even if NVAC dropped back down to $10 per share at that time, it still would be a 500% ROI.
Only time will tell.
Last few days I have seen big selling in NVACW and NVACR (with concurrent price drop down to as low as .1280).
Today I see big buying of NVAC (it is only 1:30 pm and 182,517 shares traded so far, and the stock is up 5 cents to $9.84, which is the 52 week high, with the ASK now @ $9.85
Looks to me like big players are getting rid of their rights and warrants in exchange for stock (which has a value of more than 50x of either the stocks or the warrants).
I'm guessing it is just a clean-up and consolidation.
I'm guessing the big players would rather just deal with the one larger piece of the pie (NVAC) rather than the many multiples of the much, much smaller pieces of the same pie (NVACW and NVACR).
Looks like there could be an opportunity for some good buys...
Delay in announcement of Acquisition Target?
As crazy as it sounds, and being as impartial and callous towards recent developments on the other side of the world (and just looking at this in relation to NorthView)...
I believe that the recent developments in the Ukraine (Russian troops crossed the border on 2/23/2022) will post-pone any Press Releases.
Why would a company put out a Press Release now, knowing that such PR would be tremendously overshadowed by current affairs and would dampen whatever was said in such release?
I don't feel that Putin is trying to take over the Ukraine (Why would he? The resources of interest are in the east, and those two provinces have already peacefully acknowledged their desire to leave the Ukraine and rejoin Russia). Rather, I believe Putin is looking to remove the corruption so deeply imbedded in the country and to prevent NATO from being on his border. Keep in mind this is where Hunter Biden was on the board of the Ukrainian energy company (Barisma), which is, btw, currently under Federal Investigation.
https://nypost.com/2022/02/23/hunter-bidens-hot-water-is-reaching-a-boiling-point/
Further, Putin's reason for the invasion is oddly interesting: “We will strive for the demilitarization and de-Nazification of Ukraine, as well as bringing to justice those who committed numerous bloody crimes against civilians.”
Whatever one thinks about Russia/Putin, imagine for a moment what the United States would be willing to risk if we thought for a moment that communist missiles would be just across the border (ie: Ukraine joining NATO).
Actually, you don't have to imagine. Just recall the "Cuban Missile Crisis" and how that crisis almost brought us to the brink of war.
At any rate, let's hope the Russian initiative is short lived, that Putin accomplishes his goals as quickly and with the least amount of blood-shed as possible, and that the Ukraine Crisis settles down quickly - because no matter what, this Administration does not have the strength, commitment, nor worldwide support to stop whatever it is that Putin has intentions of accomplishing.
Any push back now from the US is just going to cause more pain for Americans as well as the rest of the world. Truth be told, the time to stop Putin was months ago. This would never have happened under Trump's watch.
There is also talk of US involvement in 11 biotech labs in the Ukraine, 7 of which were targeted by Russian forces in the 1st day of the invasion. Perhaps Putin is trying to stop the next pandemic...
Bottom line: Let's hope this is short-lived, that Putin gets in with the least amount of blood-shed and accomplishes whatever it is that he wants to protect Russia's sovereignty and security (Putin has said he wants the government of Ukraine and the rest of NATO to agree not to have Ukraine join NATO), and than gets out.
...and...let's further hope China doesn't see what Russia is doing, and then decide it is time to move on Taiwan, because this administration is way too weak to be able to handle pretty much any other crisis in foreign affairs...
Once matters settle down in areas that this Administration unfortunately has absolutely no ability or strength to oppose, the world can get on with trying to become a better place.
Sentiment is souring:
NVACR has dropped to .16, the lowest I have ever seen it.
NVACW is trading about 100 shares per day, at about .19
NVAC is trading maybe a few hundred to a couple of thousand shares per day at most, at about $9.78
Things are very quiet.
Looks pretty much like most are waiting for something to happen.
I myself am taking an opportunity to sell AXIM in the .20s when I can, and put that back into NVACR at .1601 when the opportunity presents itself.
Otherwise, all quiet on the Western Front.
Good time to start getting my early Spring cleaning started - and by Spring cleaning, I mean prepping the gardens, cleaning out the garage, cutting down dead trees and hanging branches, etc.
I have no dry powder available right now to do anything except sit and wait.
Very interesting.
All I can do is watch right now.
But I will definitely keep watching to see what happens.
New Purchases by Yakira Capital Management
New Purchase: NorthView Acquisition Corp (NVACU)
Yakira Capital Management, Inc. initiated holding in NorthView Acquisition Corp. The purchase prices were between $10.02 and $10.05, with an estimated average price of $10.03. The stock is now traded at around $10.050000. The impact to a portfolio due to this purchase was 1.25%. The holding were 991,800 shares as of 2021-12-31.
That was almost $10 million.
Yakira Capital Management is a hedge fund company based in Westport, CT. They operate 1 private fund and have approximately $296.2 million in total assets under management (AUM).
Going back to post #16, here is what I believed would be the result after the split:
Here is something I just stumbled upon while searching for news about NorthView:
New Purchase by SkyView Investment Advisors, LLC: NorthView Acquisition Corp (NVACU)
SkyView Investment Advisors, LLC initiated holding in NorthView Acquisition Corp. The purchase prices were between $10.02 and $10.05, with an estimated average price of $10.03. The stock is now traded at around $10.050000. The impact to a portfolio due to this purchase was 0.47%. The holding were 200,000 shares as of 2021-12-31.
About the investment firm:
Established in 2009, our competitive edge is rooted in the deep experience of our world class, research-driven investment management team. SkyView provides comprehensive multi-asset solutions across traditional and alternative strategies designed to help you manage the complexities of your business and accomplish your goals through:
collaborative relationships built on transparency and open architecture solutions, and partnering to support investments, education, and business development.
In total, Skyview Investment Advisors manages $4,108,296,074 in assets.
They bought Units at $10.03 before the end of 2021. I purchased units in January at $10.09.
Old news, but it is nice to see an investment firm purchasing $2 million worth of NVACU at about the time the SPAC had its IPO.
After the units were split, I myself sold off the warrants and shares and focused entirely upon the Rights.
I kind of figured that the Rights carried the most risk (ie: they would have zero value if a merger is not consummated within 24 months), but I also figured that the founders of NorthView get nothing for their efforts until a merger is completed - so they have the motivation to complete a merger, even a bad one, in order to reap the fruits of their efforts.
As NVACR is for 1/10th of a Right to a share, at about .19 per NVACR, it is the equivalent of paying $1.90 for a share of NVAC, which currently is trading at $9.78.
In other words, even if the SPAC's value remained at $9.78 or even dropped, upon consummation, the Rights would still be looking at a 400% to 500% increase in value.
I just felt that since it was my intention to hold until the announcement of the acquisition target (I could still sell NVACR at that time), or even until just after the merger is completed, that NVACR held the highest risk (minimized by the personal agenda's of NorthView's founders) and therefore the highest rewards.
Its a gamble, but one that hopefully will payoff.
Godspeed.
Well, as for the Rights, I picked up 30k of the 45.6K, all @ .1751
As for NVAC - well, look at that, 418k....almost twice the average volume (222k).
Damn, that's over $4 million! That's surprising!
The warrants are merely 100 traded.
Personally, I saw the units get split into their 3 parts at almost exactly 30 days after the IPO.
NVACU IPO was 12/20/21 - 12/23/21
NVACU split into NVAC, NVACW, NVACR from 1/19/22 (announced) to 1/21/22 (Friday, close of business).
Then, 30 days after that is roughly about 2/18/2022 (today) to about 2/20/2022.
...so I just figured sometime soon might be a good time to announce an acquisition target, and that the number of days left to pick up NVACR at these levels could quickly be running out.
Maybe someone else figured likewise regarding the stock?
What's up with the high volume today.. the rights (NVACR) as well??
I further believe that the highest risk (and therefore, the highest reward), are the NVACR, which will expire worthless in 18 months to 2 years if NorthView doesn't complete an acquisition.
The thing that I believe reduces the risk is that Peter O'Rouke will get absolutely nothing for all his work with the SPAC unless he successfully completes an acquisition.
This is how the SEC prevents fraud/deceit/deception.
So I believe that NVACR may inherently have the highest risk, but that the risk is mitigated by management's desire to complete a takeover in order for management to get "paid" for all of their efforts in this matter.
Last Thursday/Friday I sold off some NVACR (at just about cost) in order to pick up AXIM, as it dipped down to .15/.16.
Hopping to turn the AXIM back in at around a 4 to 5 cent gain per share (in the .20s) this week, and then turn that back into NVACR.
Problem is that I believe time is short.
Since it only took Peter O'Rouke 30 days to break the units (NVACU) into their separate components (NVAC, NVACW, and NVACR), it might only be 30 days until he announces his acquisition target.
The shares came out 12/23, then broke into separate pieces 1/21, so another 30 days is this coming Friday (2/19).
Going to be real close if I can pull this off - unless he delays in the acquisition announcement till the following week or later.
Interesting week coming up.
March 2020 - Axim finalized acquisition of Sapphire.
April 2021 - NorthView Registered.
December 2021 - NorthView IPO.
I feel that Peter (who is on the board at Axim) saw other biotechs that Axim was looking at and decided that since Axim could only afford to acquire one (Sapphire), he would (separate from Axim) bring the next best candidate public via a SPAC - but he waited until the pandemic looked like it was going to subside (ie: March 2020 was the beginning of the lockdowns).
Having waited 1 1/2 years, I think Peter knows his target already and is looking to work quickly.
Peter could announce as early as this coming Friday (February 19, 2022).
I think the following statement from my previous post is misleading:
History shows that the best strategy here is usually to buy SPACs after they've announced a merger target but before the actual completion of the combination. Nov 16, 2021
If either deal falls through, those shares will only be worth the cash they represent – whether it's more or less than $6.67. We can be certain that these shares don't represent more than $10 in cash, so any SPAC deal that busts will quickly reflect its true value – somewhere under $10 per share. Jul 1, 2021
NVAC currently 24,168,800 shares outstanding.
Market Cap = 236,370,900 ($9.78 per share)
52 week low = $9.692
52 week high = $9.785
Average volume is 350k shares traded per day since 1/24/2022.
If a SPAC's managers can identify an appropriate acquisition target, they must then obtain approval through a shareholder vote. Investors are sent proxy materials disclosing the details of the proposed acquisition. A SPAC's public shareholders may vote in favor of the acquisition, or vote against the acquisition. If the shareholders vote against the acquisition, they may elect to have their shares converted into a pro rata portion of the IPO proceeds, which are held in an escrow account.
During the IPO stage, investors purchase units representing one or more shares of common stock and one or more warrants exercisable for one share of common stock at a discount to the offering price. Typically, a SPAC will trade as a single unit following the IPO. After a certain period, often 90 days following the IPO, the common stock and warrants trade separately.
Following the IPO, nearly all of the SPAC proceeds are held in an escrow account to be used to complete an acquisition. The escrow account typically invests in money market funds or short-term U.S. government securities. The SPAC assets are released from escrow when the shareholders approve an acquisition or the SPAC is dissolved.
Warrants (and presumably Rights) are exercisable only upon successful completion of an acquisition and typically will expire worthless if the SPAC is liquidated.
Naturally, an investment before the announcement of an acquisition is a bet on whether an acquisition target will be announced and whether it is an attractive investment.
FINRA research indicates that SPAC share prices slightly outpace the market on the day an acquisition target is announced.
FINRA research indicates that most SPAC share prices significantly lag the market after the acquisition is completed. (Bag Holders!).
If a SPAC's management identifies an appropriate acquisition target, it must then seek a shareholder vote. An acquisition by a SPAC typically requires the approval of at least 60 percent of the shareholders and some deals require 80 percent. Investors are sent proxy materials disclosing the details of the proposed acquisition.
SPAC sponsors, unless they have purchased shares of the SPAC's common stock, do not receive a pro rata distribution from the escrow account if an acquisition is not completed. In addition, they are typically prohibited from selling their shares in the secondary market prior to completion of the acquisition. These mechanisms, along with their 20 percent equity stake in the SPAC, may help to align management and investors' interest in completing an acquisition. However, SPAC managers have a strong incentive to buy a company, even at inflated values, since they will get 20 percent of the company at a nominal price.
Another thought occurs to me about the Rights and the stupidity of my concern that the Rights only turn into shares upon the consummation (completion) of the acquisition:
NVACR will, just like the warrants and the shares, continue to trade on a daily basis during the entire process.
That means, of course, that NVACR should experience the same price appreciation as NVAC and NVACW upon the announcement of the acquisition.
In other words, one doesn't have to wait till consummation in order to take advantage of any price appreciation that may occur upon the announcement of the acquisition target...
One could actually sell their NVACR at any point along the way...
The only glitch in all of my thinking is that the Rights (NVACR) do not become shares on the date of the announcement of the acquisition target (the date that I believe the share price will rise rapidly upon that PR), but rather upon the consummation of the deal (ie: the date that the acquisition is finalized!).
STILL, if I am effectively now purchasing a future share for $2 (each NVACR is about 20 cents, and it takes 10 NVACR to make 1 share), then even if the stock shot up from say $10 to $50 at the announcement of the acquisition target, and then slowly dropped back to $10 at the time of consummation, I still would be sitting on almost a 500% gain (since I am effectively purchasing the stock today at $2 per share).
Albeit, if it went from $10 to $50 (the equivalent of a 500% gain from today's stock price), and then slowly dropped to someplace above $10 by the time of consummation, I still would be sitting on a 500%+ gain (keeping in mind my cost per share was originally $2).
AND, in the highly improbable event that I could sell at the high of $50, then I'd be looking at a 2,500% gain (lol times 1,000).
Finally, if the stock dropped to 1/5th of its current value (ie: from $10 to $2), then I would be at a break even point.
Every way I look at it, IF the SPAC consummates a deal, you just don't seem to be able to lose with NVACR....
...IF the SPAC consummates a deal......
And that is worth repeating one more time.....
...IF the SPAC consummates a deal......
....which, after all, is exactly what the SPAC is supposed to do and the original purpose for the SPAC to be formed.....
......to consummate a deal......
The IPO launched on 12/23/21, and less than a month later (1/21/22) they were already splitting up the Units into their 3 separate parts.
This is an absolute 1st necessary step before the SPAC announces its target, and I am thinking it is probably an SEC requirement (ie: 30 days minimum), and I'll be damned if the SPAC didn't do the split on the absolute very first day that it possibly and legally could!
I further wouldn't doubt that there is another 30 day requirement before the SPAC can announce it's target, which would then put us at exactly February 20th (10 days to the end of January, then 20 days to the 20th of February).
2/20/2022
Do you recognize that date?
Funny how THAT was the date that I was posting on the AXIM board as the latest date out for the Immunopass EUA!
Earliest was 2/2/22, latest 2/20/2022 (my senses "tingle" in palindromes)
Seems I am going to have to fine tune my ability to understand when my "spider senses" are firing off. I mean, if the SPAC announces a target on or around that date, I'm just going to have to say that I simply got my wires crossed!
LOL.
Certainly should be fun seeing how this all pans out...
I added these to my Yahoo watch list awhile back. I still try to take a look every now and then.
Maybe I can invest in the warrants in a small position soon.
If nothing else, covid19 caused the biotech field to become a popular risk/reward in this market.
This afternoon I have quite a substantial bid (over 100k shares) for NVACR @ .18, and I'm not planning on raising it - ever.
The Ask is at a firm .2077, volume so far today is just 658 shares (it is just after 1:30 PM EST).
If anyone wants to move any respectable amount of shares of NVACR, either today or into the predictable near future, then they will have to come down to my Bid, and soon.....
....because, I am watching the media coverage on the Immunopass battle cry of Marker of Immunity starting to take hold, and soon I will be moving this play over to AXIM, which is truly starting to peak my interests at this time................
So I have pretty much sold off all of the shares (NVAC) and most of the warrants (NVACW) in exchange for the Rights (NVACR).
I'm using my logic, that owning future rights to a share, at 1/5th of the cost of a current share, is the best bang for the buck, especially if one's intention has always been to hold and to only sell AFTER the announcement of the target.
After all, today's shares and today's future shares will be exactly equivalent at that time (except, of course, for how much they originally cost).
Seems to me that such a move would be the equivalent to almost a 500% gain, provided the stock value doesn't decrease upon the announcement of a target (which it truly shouldn't).
Truth is that I now only have the equivalent of 2.4 times the amount of "future" stock that I had of "present" stock, as I have not yet used up all of the dry powder (ie: I am about 75% along the way, and now want to see if I can pick up some cheapies over the next 2 1/2 weeks) AND I am spending a little of that extra dry powder whenever AXIM drops below 19 cents.
Still, 2.4 times is like a 240% increase, or if being pessimistic, the stock price after acquisition could drop to a little over $4 and I still won't have realized a loss (and by selling the warrants, I further reduce the downside of the stock trading under $11.50 - the target price of the warrants).
LOL, this is kind of like riding "Dueling Dragons" at Disney, only like being on both rollercoaster rides at the same time!
The more I think on it, the more I am convinced that the Rights (NVACR) are the best way to go.
You can own 1 share of stock today @ $9.75 (Total cost for a share at desired selling time will have been = $9.75)
You can own the right to buy 1 share (@ $11.50) in the future for about $0.20 (Total cost for a share at desired selling time will have been = $11.70)
OR, you can buy the Rights to 1 future share for $2.00 (you would need to purchase 10 NVACR today at a cost of $0.20 each). (Total cost for a share at desired selling time will have been = $2.00)
If I am reading this correctly, those Rights go into effect "after a merger has commenced", which means upon the announcement of a merger target (or very soon thereafter).
Since it has always been my intention to wait until after a merger has been announced in order to sell any interests in NorthView Acquisition Corp., then owning shares or owning Rights to shares makes no difference.
In effect, the Rights give you the ability to own almost 5 times as many (whole) shares (4.875 times), which turns your investment into an automatic 487.5% gain upon the Announcement of the Acquisition Target (AOTAT) even if the current sales price for NVAC remains the same after the announcement!
If post AOTAT the price drops substantially, it would have to drop by almost 80% for you to experience a loss.
If post AOTAT the price rises, your gain could well be above 500%
Based on the above, I have a NVAC sale price target of $14.25. This would be a % increase above today's value ($9.75) of + 46%, with an effective % Rate of Return of more like over 600%.
Damn, I hope my calculations and my thinking are correct.
Godspeed.
I'm still reading and watching.
Interesting.
In a couple of weeks, I might be able to start a position in NVACR or
NVACW
Those are more in my price range.
My thoughts are that the stock (NVAC) and the rights (NVACR) will add value if the stock price rises, but it is the options/warrants (NVACW) that promise to deliver the greatest % return when the time comes (ie: announcement of acquisition - AOA).
Since the intent is to sell all 3 (NVAC, NVACR, NVACW) upon AOA, then wouldn't it make sense to sell NVAC now in exchange for NVACW?
(With the basic assumption that an AOA will occur, which is the sole purpose of the SPAC to begin with).
For that matter, upon AOA, since NVACR is 1/10th of NVAC, wouldn't it be better to sell NVAC now in exchange for NVACR, since NVAC is currently $9.74 and NVACR is much less than 1/10th of that?
NVACR is currently trading at about .17, but 1/10th of what NVAC is currently trading at is .974, so if you sell NVAC and buy NVACR, you essentially are getting more than 5x as much stock upon AOA that will be trading at (1/10th of) the price of NVAC upon AOA.
In other words, if the AOA occurred tomorrow, and NVAC remained at today's value of $9.74, then NVACR would be worth 1/10th of that, or $.974 - which is 5.7 times what it is worth today!
Doesn't that turn NVACR into an immediate, guaranteed 5 bagger upon AOA?
Going to have to sleep on this, but it seems that shifting $ out of NVAC and into NVACR and NVACW might be the prudent thing to do.....PROVIDING that the SPAC does what its whole "reason for being" is to do - Take over a acquisition target.
If my calculations are correct, then taking into consideration any "fully convertible" units purchased (ie: there is no loss because of fractions in the total number of units purchased), if you take the final share price after a target is announced and multiply that price by 1.14, then you will have the actual value of your investment (taking into consideration all of the Rights and Warrants) - as long as the final share price is above $11.50.
In other words, if NVAC goes to $15 per share, and you have a full compliment of warrants and rights from when you purchased an even number of units, then the additional value of those warrants and shares adds another .43 to the share price:
$15 x 1.14 = $17.10
So, when the time comes, those warrants and rights will add another 14% to your gross proceeds.
Now, the higher the stock price, the greater the % return from the warrants and rights:
$11.50 = 10.00% (the warrants add no value at this price)
$15.00 = 21.67%
$20 = 31.25%
$25 = 37.00%
$30 = 40.83%
$35 = 43.57%
$40 = 45.63%
"options" can return much bigger percentage gains and rewards that just purchasing the stock outright by itself.
The "rights" clearly add 10% to the final value, but it is the Warrants that result in the additional ercentage gainds at higher stock prices.
Godspeed.
Day 3 after the split:
NVACW: 504,695 shares @ $0.22
NVACR: 36,436 shares @ $0.19
NVAC: 1,575,400 shares @ $9.74
The numbers seem odd.
Should wait about a week or so to see how these numbers settle in.
Wow, yesterday - the 1st day post the unit split - was some day!
NVACW: 504,695 shares @ $0.21
NVACR: 1,590,700 shares @ $0.16
NVAC: 1,575,400 shares @ $9.70
There was a single trade of NVAC of over $4.6 million!
Total dollars worth of NVAC traded yesterday was $15 million.
And, most of the action was buys, not sales (Green trades, not red ones).
MAYBE that had something to do more with the splitting up of the units and NOT actual trades?
If that be the case, then the splitting up of the units has to certainly be complete. Everything starting this morning should all be trades.
38110
The Warrants portion of the units are now trading at FULL Warrants (each Warrant gives the holder the right to purchase an entire share at $11.50 in the future), so the number of warrants received in the split was half of the total number of units purchased.
Therefore, after Day 1 of the split, the "units" were effectively trading at $10.02, a drop of 8 cents per unit.
It appears that the following is about how the units have split up, based upon LOW BIDS:
NVAC = $9.67
NVACW = $0.22
NVACR = $0.20
....as of 1/25/2022 (1 day after split).
38110
NVAC was $9.71, NVACW closed at .22, NVACW was at .20, totaling to $10.13
The splitting of the Units has occurred, and today the new symbols are trading as follows:
NVAC $9.70 - $9.93 (0 trades so far)
NVACW $0.24 - $0.25 (141K trades)
NVACR $0.23 - $0.30 (0 trades so far)
From post #16, these were my calculations:
When you can, you might as well have fun doing it.
I played a few SPACs in 2021, and I feel I have learned a lot (from my mistakes).
Buying on "rumor" is what is occurring now. Selling on the "News" is what occurs very quickly soon after the merger/acquisition target is announced.
Also, the splitting up of a unit into its parts, to be traded separately, is a good sign that the "news" is coming soon. The Warrants and the Rights really have no value at this time, but they will once the target is secured. Splitting up the units after an announcement is just too complicated.
I think that the PR from two days ago speaks volumes. I believe a target has been found.
If you look at the chart of a typical SPAC, you will see that the best time to sell is immediately after the target of that SPAC is announced.
After that initial pop, the stock continues to slowly drop in value.
Fortunately, the stock never goes back to its pre-target announcement days, but the best profits can be found right after the acquisition news is PR'd.
Now, with the Units being split into their pieces, and 2 of the 3 pieces essentially worthless until a merger occurs, I'm thinking that is coming real soon.
I'm just going to sit tight till that something happens.
Godspeed.
38110
took a small position today. Kinda like playing 5 card stud and hanging around to get that last card.
Thinking along the lines of the dividing up of units that will occur after the close of business tonight:
After the split, there will be a price for a share, = X
The price for a Right should then be no greater than .1X (That is, 1/10th of the price of a future share)
The price of a warrant has to be X - $11.50, since why would you pay for a warrant to buy a share in the future for $11.50, if you could buy that share today for X?
Since, as of today, X - 11.50 would be a negative number, we must leave the warrants out of the equation in order for the equation to make any sense (that is, the Warrants will be worth almost nothing after the unit is split into its parts. Let's assign it a value of .01).
Therefore, using the following equation, where NVACU is the current unit price today of $10.10:
NVACU = NVAC + NVACR + NVACW
$10.10 = X + .1X +.01
Solving for X, which should be the price of a share of NorthView comes next week, we see roughly:
NVAC = $9.18
NVACW = $.01 (just to give it a minimum value)
NVACR = $.91
So, I am going to say that, since NVACR only has value when a business relationship is consummated sometime in the future, then comes end of next week, the split up units will be trading more likjely as follows:
NVAC.......... = $9.80 to $9.95
NVACW....... = $0.01 to $0.05
NVACR....... = $0.30 to $0.40
LOL....let's see how far off I am.
35440
Good luck with your investments as well. Hope the NVACU works out for you.
I'm still thinking there is a focus on EmpoweredDiagnostics.
My big idea is for Empowered Diagnostics to eventually merge with AXIM and Empowered management to eventually run the combined company.
But that is just me.
I'll keep them in mind, but I did go all in with NVACU these last 2 weeks, so capital is tied up for a bit.
I see NorthView as a quick in and out, with the possibility to double or triple the investment in a very short time.
I have no intentions of holding a share, a warrant, or a right more than 3 or 4 days after they PR a target.
Really, with the amount of shares I picked up, I should be able to get out in less than a day.
Good luck with all your investments.
Yes. August 2021.
Northview Acquisition will only be a curiosity for me. I don't have any plans or money to invest in Northview.
But will continue to add cheap AXIM shares at these prices.
Another penny stock Biotech/Biopharma I like is ACRX with FDA approved DSUVIA (DSUVIO in Europe). Lots of great news in 2021. Also a $30 million contract with department of defense.
Price of ACRX is very beat down. 2022 should be the year the tide finally turns. Acquisition of Lowell Therapeutics in late 2021.
My apologies, those years (2020 and 2021) were so clear in my previous post, I don't know how that got past me.
Then again, August 2022? Are you looking into a crystal ball, because that's like 7 months in the future........
Sapphire Biotech was acquired in 2020.
Advanced Tear Diagnostics was acquired 16 months later in August 2021.
I would have to look at my StockTwits posts, but I think I found the Northview Acquisition Corporation information in July 2021.
Then in August 2022, AXIM announced their Acquisition of the Dry Eye Disease tests from Advanced Tear Diagnostics LLC.
Catalina Valencia (CEO of Sapphire Biotech) was a past Chief Legal Officer of Advanced Tear Diagnostics LLC.
Yes, there is. Peter's involvement with NorthView is completely transparent.
A thought occurred to me yesterday:
Did you say that you were watching NorthView from about April 2021? I found this in the media:
I took the bait and will follow this board for awhile.
Personally I don't own any shares yet, but I am curiously watching Northview Acquisition Corporation.
It is very Curious that Peter O'Rourke is Chairman of this Board and also on the board of directors for AXIM.
At the very least there has to be openness between Peter O'Rourke and the AXIM bod as to what his intentions are.
At close of business on January 21, 2022, the Units of NVACU were split as follows:
Before COB on 1/21/2022:
NVACU = the "Unit", which consisted of 1 share, 1/2 warrant, and 1/10th Right
After COB on 1/21/2022:
NVAC = Common Share
NVACW = A Warrant, 1 Warrant issued for every 2 units owned, no warrants for a single (or odd numbered) unit, warrants are for the future purchase of a share of NVAC @ $11.50, regardless of the market price.
NVACR = Rights, 1/10th of a Right issued for every unit. Apparently, there will be shares issued in 10ths, as I have not seen a restriction as to ownership of fractions of units in lots less than 10 units. The Right is for 1/10th of a common share upon the successful consummation ("joining") of a business relationship.
By buying units in lots of 10, an investor will not lose in the case of a half warrant (since the units purchased are in even numbers), AND the investor will NOT wind up with any fractional shares upon business consummation.
With yesterday's Press Release, stating that comes the close of business this Friday (1/21/2022), the NorthView "units" currently being sold (NVACU) will be split into three pieces and thereafter trade as three separate entities (NVAC for the shares portion, NVACR for the Rights portion, and NVACW for the Warrants portion), I shot off my last round of purchases, achieving a share level slightly more than I had originally expected.
Now it is just a matter of waiting for "the News" (ie: the "rumors" portion, for me at least, has come to a close).
Interestingly, the average share volume is currently being reported at 361,957 shares per day, with today's volume so far just at 6,479 shares (of which, a certain blind squirrel had a hand in 85% of them).
My thoughts are two-fold:
1. Splitting up the units into three separate pieces, each of which is to be traded separately, must be a sign that the SPAC is quickly moving forward (ie: a target has been found). CLEARLY, the warrants to buy NVAC at $11,50 have absolutely no value today, since even in tact entire units are trading way under that value ($10.10 per unit). The same is true of the Rights, which only kick in when NorthView consummates a deal of some sort. Currently, those Rights are worthless, especially when one considers that if a merger doesn't occur within 2 years, all of the $ collected by the SPAC must be returned, and the Rights will have absolutely no value. So my thoughts are, the only logic in splitting the units now into 3 separately tradeable entities, is that there is an event coming, in the very near future, that will make each separate entity worth trading (and THAT is most likely an announcement of an acquisition target).
2. Most of the time, when you split things up, the value of the pieces is greater than the value of the whole (think about how a car's parts are worth more than the car itself, or how after a stock split, the new sum of the parts are worth more than the original whole). Along those lines, anyone who just wanted to own Shares would have had (up unto close of business tomorrow) to buy entire units, and essentially "pay something extra" for the two other pieces (Rights and Warrants) which they didn't want. NOW, however, starting next week, anyone who wishes only to hold shares can (theoretically) sell off the Rights and/or Warrants that they are not interested in, and anyone who just wants Shares and nothing else now has the ability to acquire exactly what they want. Here to, in this situation, the sum total of the parts should ultimately turn out to be greater than the unit as a whole. In other words, the $10.10 spent on a unit today will have a (slightly) greater value when the parts are summed up next week (such as $10.15?, etc.).
If nothing else, the Press Releases shows progress moving forward, which is the whole purpose of the SPAC....to move forward and actually "buy" something.
35330
NorthView Acquisition Corp. announced today that, on January 21, 2022, the Company’s units will no longer trade as "a unit", which originally consisted of:
NVACU (the "U" meaning "Unit"):
1 share,
1/10th of a RIGHT to a share to be issued upon a merger,
1/2 of a WARRANT TO PURCHASE the stock at $11.50 (regardless of market price),
will after this Friday, now be split into and trade under the separate symbols:
Common Stock (NVAC),
Rights (NVACR)
Redeemable Warrants (NVACW),
https://www.globenewswire.com/news-release/2022/01/19/2369708/0/en/NorthView-Acquisition-Corp-Announces-Upcoming-Automatic-Unit-Separation.html
NorthView Acquisition Corp. is a blank check company organized for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses or entities. The Company intends to focus its initial search on target businesses in the healthcare sector with an enterprise value of approximately $500 million to $2 billion.
Followers
|
3
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
121
|
Created
|
01/17/22
|
Type
|
Free
|
Moderators |
NorthView Acquisition Corp. is a blank check company organized for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses or entities. The Company intends to focus its initial search on target businesses in the healthcare sector with an enterprise value of approximately $500 million to $2 billion. On January 19, 2022, NorthView announced that its unit (NVACU), which consisted of 1 share, 1/2 warrant (to buy shares at $11.50), and 1/10th of a right (to a share after a merger has commenced) would be split into 3 different trading symbols as such: NVAC = common shares, NVACW = Warrants, NVACR = Rights. Accordingly, any fractions would be rounded downward, so any purchases of the "unit" (NVACU) prior to this date, should best be done in groups of 2 units, or 10 units if you are not interested in potentially having fractions of a share once a relationship with another company is consummated.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |